Pacific Pharma, Inc.

Manufacturer Details

There are currently no manufacturer details available.

Pacific Pharma, Inc. Drugs

Brimonidine Tartrate So...

Brimonidine Tartrate Solution Drops

The recommended dose is one drop of Brimonidine tartrate ophthalmic solution in the affected eye(s) three times daily, approximately 8 hours apart.

Brimonidine tartrate ophthalmic solution may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic product is being used, the products should be administered at least 5 minutes apart.
Ketorolac Tromethamine ...

Ketorolac Tromethamine Solution Drops

The recommended dose of ketorolac tromethamine ophthalmic solution is one drop four times a day in the operated eye as needed for pain and burning/stinging for up to 4 days following corneal refractive surgery.

Ketorolac tromethamine ophthalmic solution has been safely administered in conjunction with other ophthalmic medications such as antibiotics, beta blockers, carbonic anhydrase inhibitors, cycloplegics, and mydriatics.
Gentamicin Sulfate Solu...

Gentamicin Sulfate Solution Drops

Instill one or two drops into the affected eye(s) every four hours. In severe infections, dosage may be increased to as much as two drops every hour.
Polymyxin B Sulfate And...

Polymyxin B Sulfate And Trimethoprim Sulfate

In mild to moderate infections, instill one drop in the affected eye(s) every three hours (maximum of 6 doses per day) for a period of 7 to 10 days.
Prednisolone Acetate Su...

Prednisolone Acetate Suspension Drops

Shake well before using. Instill one to two drops into the conjunctival sac two to four times daily. During the initial 24 to 48 hours, the dosing frequency may be increased if necessary. Care should be taken not to discontinue therapy prematurely.

If signs and symptoms fail to improve after 2 days, the patient should be re-evaluated (see PRECAUTIONS).
Fluorometholone Solutio...

Fluorometholone Solution Drops

Shake well before using. Instill one drop into the conjunctival sac two to four times daily. During the initial 24 to 48 hours, the dosing frequency may be increased to one application every four hours. Care should be taken not to discontinue therapy prematurely.

If signs and symptoms fail to improve after two days, the patient should be re-evaluated (see PRECAUTIONS).

The dosing of fluorometholone ophthalmic suspension 0.1% may be reduced, but care should be taken not to discontinue therapy prematurely. In chronic conditions, withdrawal of treatment should be carried out by gradually decreasing the frequency of applications.
Flurbiprofen Sodium Sol...

Flurbiprofen Sodium Solution Drops

A total of four (4) drops of flurbiprofen sodium ophthalmic solution 0.03% should be administered by instilling one (1) drop approximately every 1/2 hour beginning 2 hours before surgery.
Levobunolol Hydrochlori...

Levobunolol Hydrochloride Solution Drops

The recommended starting dose is one to two drops of levobunolol HCl ophthalmic solution 0.5% in the affected eye(s) once a day. Typical dosing with levobunolol HCl 0.25% is one to two drops twice daily. In patients with more severe or uncontrolled glaucoma, levobunolol HCl 0.5% can be administered b.i.d. As with any new medication, careful monitoring of patients is advised.

Dosages above one drop of levobunolol HCl 0.5% b.i.d. are not generally more effective. If the patient's IOP is not at a satisfactory level on this regimen, concomitant therapy with dipivefrin and/or epinephrine, and/or pilocarpine and other miotics, and/or systemically administered carbonic anhydrase inhibitors, such as acetazolamide, can be instituted. Patients should not typically use two or more topical ophthalmic beta-adrenergic blocking agents simultaneously.

Pacific Pharma, Inc.

Manufacturer Details

Share This Page

Pacific Pharma, Inc. Drugs